Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...

Z526- a novel dithiocarbamate-like compound reverses cancer associated cachexia via mitigating NF-B signaling and oxidative ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Turmeric (Curcuma longa), a vibrant yellow spice, a rhizomatous herbaceous plant from the ginger family (Zingiberaceae), has ...

Plant pests such as bacteria and fungi lead to significant yield losses in agriculture. In order to develop new strategies ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Maternal microbiome-derived metabolites during pregnancy impact offspring stem cell function, offering potential therapeutic ...

Matrigel Market is Segmented by Type (Contains Phenol Red, Phenol Red Free), by Application (Biotechnology and Pharmaceutical Companies, Research and Academic Institutes).

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming ...

An IBEC-led study describes the development of an innovative method to control the formation of crypt-like structures and ...

Cartalax peptide, a bioregulator derived from cartilage tissue, has garnered significant interest in scientific communities ...